QA: Agile Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2018_Agile_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001261249, Agile Therapeutics INC

  xvar xval
0 AssetsCurrent 36,714,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 13,863,000
3 remainder_Assets 18,000
4 LiabilitiesCurrent 14,272,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,134,330
9 ResearchAndDevelopmentExpense 10,311,153
10 remainder_Expenses 111,550
11 remainder_Revenues 0
12 remainder_NetIncome 117,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 50,595,000
1 Liabilities 14,272,000
2 Expenses 27,557,033
3 Revenues 0
4 StockholdersEquity 36,323,000
5 NetIncome -27,440,033
6 ComprehensiveNetIncome -27,440,033
7 BaseVar 46,270,516
8 EconomicCapitalRatiobeforeLimitedLiability 1.60
9 EconomicCapitalRatio 2.75

Edgar->Model Mapping

Feature Distribution

Change over Time